文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

评估感染性休克伴低灌注及乳酸大于4 mmol/L患者推荐的30 cc/kg液体剂量

Evaluation of the Recommended 30 cc/kg Fluid Dose for Patients With Septic Shock and Hypoperfusion With Lactate Greater Than 4 mmol/L.
PubMed 文献 · Crit Care Explor · 2023-07-13
一句话结论多中心回顾性研究显示,脓毒症乳酸大于4 mmol/L患者中,液体剂量高于或低于推荐30 cc/kg均未改善乳酸清除或结局,大于50 cc/kg理想体重者死亡率更高。

该多中心回顾性观察研究纳入脓毒症、初始乳酸大于4 mmol/L且在3小时内接受适当抗生素的患者,按3小时内晶体液剂量(cc/kg理想体重)分为五组,以25.1-35 cc/kg组为参照。多线性回归显示,参照组与其他各组在乳酸正常化、观察/预期费用及观察/预期住院时间上均无显著差异。与推荐剂量相比,接受大于50 cc/kg理想体重液体的患者死亡率更高。作者认为高或低液体剂量均未带来更好的乳酸清除或患者结局。

要点

  • 研究纳入脓毒症、初始乳酸大于4 mmol/L且在3小时内接受适当抗生素的患者,以3小时内晶体液25.1-35 cc/kg理想体重组为参照。
  • 多线性回归显示,参照组与其他液体剂量组在乳酸正常化上均无显著差异。
  • 参照组与其他液体剂量组在观察/预期费用和观察/预期住院时间上均无统计学显著差异。
  • 与推荐剂量(25.1-35 cc/kg理想体重)相比,接受大于50 cc/kg理想体重液体的患者死亡率更高。
  • 作者结论:脓毒症乳酸大于4 mmol/L患者中,高或低液体剂量均未与更好的乳酸清除或患者结局相关。

适用人群与场景

  • 脓毒症患者,初始乳酸值大于4 mmol/L,且在3小时内接受了适当抗生素治疗。
  • 研究场景为美国东北部八家医院组成的城市医疗系统,多中心回顾性观察。
  • 研究未报告排除人群。

诊断标准与关键阈值

  • 脓毒症识别后3小时内晶体液剂量分组:小于15 cc/kg理想体重、15.1-25 cc/kg理想体重、25.1-35 cc/kg理想体重、35.1-50 cc/kg理想体重、大于50 cc/kg理想体重。
  • 以接受25.1-35 cc/kg理想体重液体剂量组为参照组。

研究设计与关键结果

  • 研究设计为多中心回顾性观察研究,纳入美国东北部八家医院城市医疗系统内脓毒症、初始乳酸大于4 mmol/L且3小时内接受适当抗生素的患者。
  • 共纳入患者:小于15 cc/kg理想体重组371例(25%),15.1-25 cc/kg理想体重组278例(17%),25.1-35 cc/kg理想体重组316例(21%),35.1-50 cc/kg理想体重组319例(21%),大于50 cc/kg理想体重组207例(14%)。
  • 平均年龄66岁,56%为男性。
  • 多线性回归后,参照组(25.1-35 cc/kg理想体重)与任何其他液体组之间乳酸正常化均无显著差异。
  • 参照组与任何其他液体组之间,观察/预期费用无统计学显著差异。
  • 参照组与任何其他液体组之间,观察/预期住院时间无统计学显著差异。
  • 与推荐剂量(25.1-35 cc/kg理想体重)相比,接受大于50 cc/kg理想体重液体的患者死亡率更高。

证据类型、等级与局限

  • 证据类型:多中心回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,在脓毒症乳酸大于4 mmol/L患者中,高或低液体剂量均未与更好的乳酸清除或患者结局相关。
  • 作者结论指出,3小时内接受大于50 cc/kg理想体重液体剂量与更高的死亡率相关。
  • 原文未据此给出推荐。

指南或共识出处

  • Surviving Sepsis Campaign指南推荐:对脓毒症且乳酸大于4 mmol/L的患者,在识别后3小时内给予30 cc/kg理想体重液体。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

UNLABELLED: The Surviving Sepsis Campaign Guidelines recommend fluid administration of 30 cc/kg ideal body weight (IBW) for patients with sepsis and lactate greater than 4 mmol/L within 3 hours of identification. In this study, we explore the impact of fluid dose on lactate normalization, treatment cost, length of stay, and mortality in patients with lactate greater than 4.

DESIGN: Multicenter retrospective observational study.

SETTING: Eight-hospital urban healthcare system in Northeastern United States.

PATIENTS: Patients with sepsis, initial lactate value greater than 4 mmol/L, and received appropriate antibiotics within 3 hours.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We stratified patients into five groups based on the dose of fluid administered within 3 hours after sepsis identification. The groupings were less than 15 cc/kg IBW, 15.1-25 cc/kg IBW, 25.1-35 cc/kg IBW, 35.1-50 cc/kg IBW, and greater than 50 cc/kg IBW. We used the group that received a fluid dose of 25.1-35 cc/kg IBW, as a reference group. The mean age was 66 years, and 56% were male. Three hundred seventy-one (25%) received less than 15 cc/kg of IBW of crystalloid fluid, 278 (17%) received 15-25 cc/kg of IBW, 316 (21%) received 25.1-35 cc/kg of IBW, 319 (21%) received 35.1-50 cc/kg of IBW, and 207 (14%) received greater than 50 cc/kg of IBW. After multilinear regression, there was no significant difference in lactate normalization between the reference group and any of the other fluid groups. We also found no statistically significant difference in the observed/expected cost, or observed/expected length of stay, between the reference group and any of the other fluid groups. Mortality was higher among patients who received greater than 50 cc/kg IBW when compared to the recommended dose.

CONCLUSIONS: In patients with sepsis and lactate value greater than 4 mmol/L, high or low fluid doses were not associated with better lactate clearance or patient outcomes. Greater than 50 cc/kg IBW dose of fluids within 3 hours is associated with higher mortality.

来源:Crit Care Explor,查看原文。版权归原作者所有。

参考来源

  1. Yohannes S, Serafim LP, Slavinsky V, et al. Evaluation of the Recommended 30 cc/kg Fluid Dose for Patients With Septic Shock and Hypoperfusion With Lactate Greater Than 4 mmol/L. Crit Care Explor. 2023. PMID: 37457917. doi:10.1097/CCE.0000000000000932

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。